| Year |
Citation |
Score |
| 2023 |
Rocchetti J, Fasano C, Dal-Bo G, Guma E, El Mestikawy S, Wong TP, Fakhfouri G, Giros B. Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride. Plos One. 18: e0289770. PMID 37624765 DOI: 10.1371/journal.pone.0289770 |
0.81 |
|
| 2023 |
Isingrini E, Guinaudie C, Perret L, Guma E, Gorgievski V, Blum ID, Colby-Milley J, Bairachnaya M, Mella S, Adamantidis A, Storch KF, Giros B. Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission. Biomolecules. 13. PMID 36979445 DOI: 10.3390/biom13030511 |
0.73 |
|
| 2022 |
Petrelli F, Zehnder T, Laugeray A, Mondoloni S, Calì C, Pucci L, Molinero Perez A, Bondiolotti BM, De Oliveira Figueiredo E, Dallerac G, Déglon N, Giros B, Magrassi L, Mothet JP, Mameli M, et al. Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice. Biological Psychiatry. PMID 36958999 DOI: 10.1016/j.biopsych.2022.11.018 |
0.325 |
|
| 2021 |
Rebeillard F, De Gois S, Pietrancosta N, Mai TH, Lai-Kuen R, Kieffer BL, Giros B, Massart R, Darmon M, Diaz J. The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex. Cerebral Cortex (New York, N.Y. : 1991). PMID 34247243 DOI: 10.1093/cercor/bhab224 |
0.755 |
|
| 2020 |
Bhardwaj SK, Cui Q, Moquin L, Gratton A, Giros B, Srivastava LK. Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors. Neuropharmacology. 108440. PMID 33340529 DOI: 10.1016/j.neuropharm.2020.108440 |
0.373 |
|
| 2019 |
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse FC, Brabet I, Laras Y, Bertrand HO, Acher F, Pin JP, Puel JL, ... Giros B, et al. LSP5-2157 a new inhibitor of vesicular glutamate transporters. Neuropharmacology. 107902. PMID 31811873 DOI: 10.1016/J.Neuropharm.2019.107902 |
0.747 |
|
| 2019 |
Orrico-Sanchez A, Chausset-Boissarie L, Alves de Sousa R, Coutens B, Rezai Amin S, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T, Gruszczynski C, Giros B, Guiard BP, Acher F, Pietrancosta N, et al. Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression. Molecular Psychiatry. PMID 31619760 DOI: 10.1038/S41380-019-0548-4 |
0.661 |
|
| 2019 |
Cavarec F, Krauss P, Witkowski T, Broisat A, Ghezzi C, De Gois S, Giros B, Depaulis A, Deransart C. Early reduced dopaminergic tone mediated by D3 receptor and dopamine transporter in absence epileptogenesis. Epilepsia. PMID 31535376 DOI: 10.1111/Epi.16342 |
0.789 |
|
| 2019 |
Giguère N, Delignat-Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, Anand-Srivastava M, Gether U, Giros B, Trudeau LÉ. Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout. Plos Genetics. 15: e1008352. PMID 31449520 DOI: 10.1371/Journal.Pgen.1008352 |
0.379 |
|
| 2019 |
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu AP, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM, Giros B. Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration. Scientific Reports. 9: 7850. PMID 31127135 DOI: 10.1038/S41598-019-43955-4 |
0.813 |
|
| 2019 |
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å. The NeuroD6 subtype of VTA neurons contributes to psychostimulant sensitization and behavioral reinforcement. Eneuro. PMID 31097625 DOI: 10.1523/ENEURO.0066-19.2019 |
0.308 |
|
| 2019 |
Mongrédien R, Erdozain AM, Dumas S, Cutando L, Del Moral AN, Puighermanal E, Rezai Amin S, Giros B, Valjent E, Meana JJ, Gautron S, Callado LF, Fabre V, Vialou V. Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons. Brain Structure & Function. PMID 30656447 DOI: 10.1007/S00429-019-01831-X |
0.667 |
|
| 2018 |
Nair AG, Castro LRV, El Khoury M, Gorgievski V, Giros B, Tzavara ET, Hellgren-Kotaleski J, Vincent P. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia. Neuropharmacology. PMID 30468798 DOI: 10.1016/J.Neuropharm.2018.11.029 |
0.722 |
|
| 2018 |
Petrelli F, Dallérac G, Pucci L, Calì C, Zehnder T, Sultan S, Lecca S, Chicca A, Ivanov A, Asensio CS, Gundersen V, Toni N, Knott GW, Magara F, Gertsch J, ... ... Giros B, et al. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Molecular Psychiatry. PMID 30127471 DOI: 10.1038/S41380-018-0226-Y |
0.442 |
|
| 2018 |
Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JP, Grenier J, Ibrahim EC, El Khoury MA, Tse YC, Mongredien R, Barbé A, de Macedo CEA, Jaworski W, Bochereau A, Orrico A, ... ... Giros B, et al. Antidepressive effects of targeting ELK-1 signal transduction. Nature Medicine. PMID 29736027 DOI: 10.1038/S41591-018-0011-0 |
0.774 |
|
| 2018 |
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM, Giros B. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage. PMID 29704613 DOI: 10.1016/J.Neuroimage.2018.04.054 |
0.808 |
|
| 2017 |
Dos Santos M, Cahill EN, Bo GD, Vanhoutte P, Caboche J, Giros B, Heck N. Cocaine increases dopaminergic connectivity in the nucleus accumbens. Brain Structure & Function. PMID 29027032 DOI: 10.1007/S00429-017-1532-X |
0.428 |
|
| 2017 |
Isingrini E, Guinaudie C, C Perret L, Rainer Q, Moquin L, Gratton A, Giros B. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice. Scientific Reports. 7: 12432. PMID 28963508 DOI: 10.1038/S41598-017-12810-9 |
0.769 |
|
| 2017 |
Erdozain AM, De Gois S, Bernard V, Gorgievski V, Pietrancosta N, Dumas S, Macedo CE, Vanhoutte P, Ortega JE, Meana JJ, Tzavara ET, Vialou V, Giros B. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28905875 DOI: 10.1038/Npp.2017.217 |
0.838 |
|
| 2017 |
Xu Y, Lu Y, Xu P, Mangieri LR, Isingrini E, Xu Y, Giros B, Tong Q. VMAT2-Mediated Neurotransmission from Midbrain Leptin Receptor Neurons in Feeding Regulation. Eneuro. 4. PMID 28560316 DOI: 10.1523/ENEURO.0083-17.2017 |
0.301 |
|
| 2017 |
Fasano C, Rocchetti J, Pietrajtis K, Zander JF, Manseau F, Sakae DY, Marcus-Sells M, Ramet L, Morel LJ, Carrel D, Dumas S, Bolte S, Bernard V, Vigneault E, Goutagny R, ... ... Giros B, et al. Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells. Frontiers in Cellular Neuroscience. 11: 140. PMID 28559797 DOI: 10.3389/Fncel.2017.00140 |
0.738 |
|
| 2017 |
Isingrini E, Perret L, Rainer Q, Amilhon B, Guma E, Tanti A, Martin G, Robinson J, Moquin L, Marti F, Mechawar N, Williams S, Gratton A, Giros B. 695. Resilience against Chronic Stress is Mediated by Noradrenergic Regulation of the Ventral Tegmental Area Biological Psychiatry. 81: S282. DOI: 10.1016/J.Biopsych.2017.02.762 |
0.765 |
|
| 2017 |
Farley S, Grenier J, Gorgievski V, Barbe A, Jaworski W, Bochereau A, Macedo C, Ghandour S, Huebner N, Bienert T, Henning J, Massaad C, Giros B, Harsan L, Tzavara E. 109. From Early Life Adversity to Adolescence Depression: White Matter Remodelling in a Translational Animal Model Biological Psychiatry. 81: S46. DOI: 10.1016/J.Biopsych.2017.02.121 |
0.506 |
|
| 2016 |
Isingrini E, Perret L, Rainer Q, Amilhon B, Guma E, Tanti A, Martin G, Robinson J, Moquin L, Marti F, Mechawar N, Williams S, Gratton A, Giros B. Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons. Nature Neuroscience. PMID 26878672 DOI: 10.1038/Nn.4245 |
0.8 |
|
| 2016 |
Erdozain A, De Gois S, Bernard V, Gorgievski V, Pietrancosta N, Macedo C, Vanhoutte P, Ortega J, Meana J, Tzavara E, Vialou V, Giros B. Snapin control of the dopamine transporter trafficking regulates amphetamine effect on mice European Neuropsychopharmacology. 26: S221-S222. DOI: 10.1016/S0924-977X(16)31076-8 |
0.473 |
|
| 2015 |
Isingrini E, Perret L, Rainer Q, Sagueby S, Moquin L, Gratton A, Giros B. Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour. Journal of Psychiatry & Neuroscience : Jpn. 41: 150028. PMID 26505143 DOI: 10.1503/Jpn.150028 |
0.771 |
|
| 2015 |
Pilorge M, Fassier C, Le Corronc H, Potey A, Bai J, De Gois S, Delaby E, Assouline B, Guinchat V, Devillard F, Delorme R, Nygren G, Råstam M, Meier JC, Otani S, ... ... Giros B, et al. Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism. Molecular Psychiatry. PMID 26370147 DOI: 10.1038/Mp.2015.139 |
0.775 |
|
| 2015 |
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MA, Bellivier F, ... ... Giros B, et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Molecular Psychiatry. 20: 1448-59. PMID 26239290 DOI: 10.1038/Mp.2015.104 |
0.784 |
|
| 2015 |
De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B. Ctr9, a protein in the transcription complex Paf1, regulates dopamine transporter activity at the plasma membrane. The Journal of Biological Chemistry. PMID 26048990 DOI: 10.1074/Jbc.M115.646315 |
0.813 |
|
| 2015 |
Doly S, Shirvani H, Gäta G, Meye FJ, Emerit MB, Enslen H, Achour L, Pardo-Lopez L, Yang SK, Armand V, Gardette R, Giros B, Gassmann M, Bettler B, Mameli M, et al. GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper. Molecular Psychiatry. PMID 26033241 DOI: 10.1038/Mp.2015.72 |
0.339 |
|
| 2015 |
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM, Gardier AM, Schinkel AH, Giros B, Gautron S. Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. Molecular Psychiatry. 20: 889-900. PMID 25092247 DOI: 10.1038/Mp.2014.86 |
0.333 |
|
| 2015 |
Rocchetti J, Isingrini E, Dal Bo G, Sagheby S, Menegaux A, Tronche F, Levesque D, Moquin L, Gratton A, Wong TP, Rubinstein M, Giros B. Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus. Biological Psychiatry. 77: 513-25. PMID 24742619 DOI: 10.1016/J.Biopsych.2014.03.013 |
0.803 |
|
| 2015 |
Blot K, Kimura S, Bai J, Kemp A, Manahan-Vaughan D, Giros B, Tzavara E, Otani S. Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801. Cerebral Cortex (New York, N.Y. : 1991). 25: 1348-61. PMID 24304584 DOI: 10.1093/Cercor/Bht329 |
0.332 |
|
| 2015 |
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MAM, Bellivier F, ... ... Giros B, et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens Molecular Psychiatry. DOI: 10.1038/mp.2015.104 |
0.729 |
|
| 2015 |
Gorgievski V, Tzavara ET, Giros B. Study of dopamine receptor and dopamine transporter networks in mice Neuromethods. 96: 305-328. DOI: 10.1007/978-1-4939-2196-6_17 |
0.348 |
|
| 2014 |
Blum ID, Zhu L, Moquin L, Kokoeva MV, Gratton A, Giros B, Storch KF. A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. Elife. 3. PMID 25546305 DOI: 10.7554/Elife.05105 |
0.426 |
|
| 2014 |
Bai J, Blot K, Tzavara E, Nosten-Bertrand M, Giros B, Otani S. Inhibition of dopamine transporter activity impairs synaptic depression in rat prefrontal cortex through over-stimulation of D1 receptors. Cerebral Cortex (New York, N.Y. : 1991). 24: 945-55. PMID 23236206 DOI: 10.1093/Cercor/Bhs376 |
0.422 |
|
| 2013 |
Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrío A, Lopez JP, Yogendran SV, Daubaras MJ, Grant A, Schmidt ER, Tronche F, Krimpenfort P, Cooper HM, Pasterkamp RJ, Kolb B, ... ... Giros B, et al. dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Translational Psychiatry. 3: e338. PMID 24346136 DOI: 10.1038/Tp.2013.105 |
0.524 |
|
| 2013 |
Lejeune S, Dourmap N, Martres MP, Giros B, Daugé V, Naudon L. The dopamine D1 receptor agonist SKF 38393 improves temporal order memory performance in maternally deprived rats. Neurobiology of Learning and Memory. 106: 268-73. PMID 24140426 DOI: 10.1016/J.Nlm.2013.10.005 |
0.388 |
|
| 2013 |
Germain J, Bruel-Jungerman E, Grannec G, Denis C, Lepousez G, Giros B, Francis F, Nosten-Bertrand M. Doublecortin knockout mice show normal hippocampal-dependent memory despite CA3 lamination defects. Plos One. 8: e74992. PMID 24073232 DOI: 10.1371/Journal.Pone.0074992 |
0.324 |
|
| 2013 |
Diaz SL, Narboux-Nême N, Trowbridge S, Scotto-Lomassese S, Kleine Borgmann FB, Jessberger S, Giros B, Maroteaux L, Deneris E, Gaspar P. Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. The European Journal of Neuroscience. 38: 2650-8. PMID 23841816 DOI: 10.1111/Ejn.12297 |
0.313 |
|
| 2013 |
Narboux-Nême N, Angenard G, Mosienko V, Klempin F, Pitychoutis PM, Deneris E, Bader M, Giros B, Alenina N, Gaspar P. Postnatal growth defects in mice with constitutive depletion of central serotonin. Acs Chemical Neuroscience. 4: 171-81. PMID 23336056 DOI: 10.1021/Cn300165X |
0.311 |
|
| 2013 |
Barth V, Need AB, Tzavara ET, Giros B, Overshiner C, Gleason SD, Wade M, Johansson AM, Perry K, Nomikos GG, Witkin JM. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. The Journal of Pharmacology and Experimental Therapeutics. 344: 501-10. PMID 23197772 DOI: 10.1124/Jpet.112.198895 |
0.409 |
|
| 2012 |
Fournet V, de Lavilléon G, Schweitzer A, Giros B, Andrieux A, Martres MP. Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. Journal of Neurochemistry. 123: 982-96. PMID 23013328 DOI: 10.1111/Jnc.12027 |
0.387 |
|
| 2012 |
Baudin A, Blot K, Verney C, Estevez L, Santamaria J, Gressens P, Giros B, Otani S, Daugé V, Naudon L. Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex. Neurobiology of Learning and Memory. 98: 207-14. PMID 22922490 DOI: 10.1016/J.Nlm.2012.08.004 |
0.318 |
|
| 2012 |
Haenisch B, Drescher E, Thiemer L, Xin H, Giros B, Gautron S, Bönisch H. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn-Schmiedeberg's Archives of Pharmacology. 385: 1017-23. PMID 22806583 DOI: 10.1007/S00210-012-0781-8 |
0.339 |
|
| 2012 |
El Khoury MA, Gorgievski V, Moutsimilli L, Giros B, Tzavara ET. Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 36-50. PMID 22300746 DOI: 10.1016/J.Pnpbp.2011.12.005 |
0.802 |
|
| 2012 |
Berthet A, Bezard E, Porras G, Fasano S, Barroso-Chinea P, Dehay B, Martinez A, Thiolat ML, Nosten-Bertrand M, Giros B, Baufreton J, Li Q, Bloch B, Martin-Negrier ML. L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 681-91. PMID 22238104 DOI: 10.1523/Jneurosci.1541-11.2012 |
0.399 |
|
| 2012 |
Fournet V, Schweitzer A, Chevarin C, Deloulme JC, Hamon M, Giros B, Andrieux A, Martres MP. The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances. Journal of Neurochemistry. 121: 99-114. PMID 22146001 DOI: 10.1111/J.1471-4159.2011.07615.X |
0.544 |
|
| 2012 |
Farley S, Dumas S, El Mestikawy S, Giros B. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801. Neuropharmacology. 62: 503-17. PMID 21945287 DOI: 10.1016/J.Neuropharm.2011.09.010 |
0.782 |
|
| 2012 |
Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry. 17: 926-39. PMID 21769100 DOI: 10.1038/Mp.2011.87 |
0.807 |
|
| 2012 |
El Mestikawy S, Fasano C, Daumas S, Giros B, Sakae D, Ramet L. S.12.04 Regulation of ‘non-glutamatergic’ transmission by the vesicular glutamate transporter VGLUT3 European Neuropsychopharmacology. 22: S129. DOI: 10.1016/S0924-977X(12)70157-8 |
0.364 |
|
| 2011 |
Narboux-Nême N, Sagné C, Doly S, Diaz SL, Martin CB, Angenard G, Martres MP, Giros B, Hamon M, Lanfumey L, Gaspar P, Mongeau R. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2538-50. PMID 21814181 DOI: 10.1038/Npp.2011.142 |
0.529 |
|
| 2011 |
Charron G, Doudnikoff E, Laux A, Berthet A, Porras G, Canron MH, Barroso-Chinea P, Li Q, Qin C, Nosten-Bertrand M, Giros B, Delalande F, Van Dorsselaer A, Vital A, Goumon Y, et al. Endogenous morphine-like compound immunoreactivity increases in parkinsonism. Brain : a Journal of Neurology. 134: 2321-38. PMID 21742735 DOI: 10.1093/Brain/Awr166 |
0.32 |
|
| 2011 |
Naef L, Moquin L, Dal Bo G, Giros B, Gratton A, Walker CD. Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring. Neuroscience. 176: 225-36. PMID 21187125 DOI: 10.1016/J.Neuroscience.2010.12.037 |
0.387 |
|
| 2010 |
Fournet V, Jany M, Fabre V, Chali F, Orsal D, Schweitzer A, Andrieux A, Messanvi F, Giros B, Hamon M, Lanfumey L, Deloulme JC, Martres MP. The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. Journal of Neurochemistry. 115: 1579-94. PMID 20969568 DOI: 10.1111/J.1471-4159.2010.07064.X |
0.527 |
|
| 2010 |
Pietrancosta N, Kessler A, Favre-Besse FC, Triballeau N, Quentin T, Giros B, El Mestikawy S, Acher FC. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorganic & Medicinal Chemistry. 18: 6922-33. PMID 20708942 DOI: 10.1016/J.Bmc.2010.06.069 |
0.742 |
|
| 2010 |
Amphoux A, Millan MJ, Cordi A, Bönisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes. European Journal of Pharmacology. 634: 1-9. PMID 20170649 DOI: 10.1016/J.Ejphar.2010.02.012 |
0.659 |
|
| 2010 |
Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2198-210. PMID 20147547 DOI: 10.1523/Jneurosci.5196-09.2010 |
0.771 |
|
| 2010 |
Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1207-18. PMID 20059803 DOI: 10.1017/S1461145709991076 |
0.583 |
|
| 2010 |
Morice E, Denis C, Giros B, Nosten-Bertrand M. Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology. 208: 57-66. PMID 19937000 DOI: 10.1007/S00213-009-1707-0 |
0.774 |
|
| 2010 |
Blot K, Kimura S, Kemp A, Manahan-Vaughan D, Giros B, Otani S. The Effect Of Non-Competitive Nmda Receptor Antagonist Mk801 On Hippocampus-Prefrontal Cortex Synaptic Responses And Executive Cognitive Function In Rats Schizophrenia Research. 117: 393-393. DOI: 10.1016/J.Schres.2010.02.710 |
0.306 |
|
| 2008 |
Ruel J, Emery S, Nouvian R, Bersot T, Amilhon B, Van Rybroek JM, Rebillard G, Lenoir M, Eybalin M, Delprat B, Sivakumaran TA, Giros B, El Mestikawy S, Moser T, Smith RJ, et al. Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. American Journal of Human Genetics. 83: 278-92. PMID 18674745 DOI: 10.1016/J.Ajhg.2008.07.008 |
0.743 |
|
| 2008 |
Vialou V, Balasse L, Callebert J, Launay JM, Giros B, Gautron S. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. Journal of Neurochemistry. 106: 1471-82. PMID 18513366 DOI: 10.1111/J.1471-4159.2008.05506.X |
0.703 |
|
| 2008 |
Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier J, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, Hanoun N, Saurini F, Kemel ML, Gasnier B, Giros B, et al. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nature Neuroscience. 11: 292-300. PMID 18278042 DOI: 10.1038/Nn2052 |
0.82 |
|
| 2008 |
Mathieu F, Miot S, Etain B, El Khoury MA, Chevalier F, Bellivier F, Leboyer M, Giros B, Tzavara ET. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behavioral and Brain Functions : Bbf. 4: 2. PMID 18201382 DOI: 10.1186/1744-9081-4-2 |
0.661 |
|
| 2008 |
Bouvrais-Veret C, Weiss S, Hanoun N, Andrieux A, Schweitzer A, Job D, Hamon M, Giros B, Martres MP. Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. Journal of Neurochemistry. 104: 745-56. PMID 18199119 DOI: 10.1111/J.1471-4159.2007.05025.X |
0.832 |
|
| 2008 |
Moutsimilli L, Farley S, El Khoury MA, Chamot C, Sibarita JB, Racine V, El Mestikawy S, Mathieu F, Dumas S, Giros B, Tzavara ET. Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways. Neuropharmacology. 54: 497-508. PMID 18155072 DOI: 10.1016/J.Neuropharm.2007.10.022 |
0.808 |
|
| 2008 |
Herzog CJ, Miot S, Mansuy IM, Giros B, Tzavara ET. Chronic valproate normalizes behavior in mice overexpressing calcineurin. European Journal of Pharmacology. 580: 153-60. PMID 18021766 DOI: 10.1016/J.Ejphar.2007.10.050 |
0.584 |
|
| 2008 |
Kashani A, Lepicard E, Poirel O, Videau C, David JP, Fallet-Bianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, El Mestikawy S. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiology of Aging. 29: 1619-30. PMID 17531353 DOI: 10.1016/J.Neurobiolaging.2007.04.010 |
0.705 |
|
| 2007 |
Khelfaoui M, Denis C, van Galen E, de Bock F, Schmitt A, Houbron C, Morice E, Giros B, Ramakers G, Fagni L, Chelly J, Nosten-Bertrand M, Billuart P. Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 9439-50. PMID 17728457 DOI: 10.1523/Jneurosci.2029-07.2007 |
0.752 |
|
| 2007 |
Bouvrais-Veret C, Weiss S, Andrieux A, Schweitzer A, McIntosh JM, Job D, Giros B, Martres MP. Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology. 52: 1691-700. PMID 17512560 DOI: 10.1016/J.Neuropharm.2007.03.015 |
0.788 |
|
| 2007 |
Vazquez V, Weiss S, Giros B, Martres MP, Daugé V. Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats. Psychopharmacology. 193: 475-86. PMID 17492273 DOI: 10.1007/S00213-007-0789-9 |
0.532 |
|
| 2007 |
Weiss S, Tzavara ET, Davis RJ, Nomikos GG, Michael McIntosh J, Giros B, Martres MP. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Neuropharmacology. 52: 1496-508. PMID 17433376 DOI: 10.1016/J.Neuropharm.2007.02.002 |
0.552 |
|
| 2007 |
Weiss S, Nosten-Bertrand M, McIntosh JM, Giros B, Martres MP. Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2465-78. PMID 17375139 DOI: 10.1038/Sj.Npp.1301385 |
0.535 |
|
| 2007 |
Morice E, Billard JM, Denis C, Mathieu F, Betancur C, Epelbaum J, Giros B, Nosten-Bertrand M. Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2108-16. PMID 17342172 DOI: 10.1038/Sj.Npp.1301354 |
0.804 |
|
| 2007 |
Crozatier C, Farley S, Mansuy IM, Dumas S, Giros B, Tzavara ET. Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants. Neuroscience. 144: 1470-6. PMID 17207580 DOI: 10.1016/J.Neuroscience.2006.11.030 |
0.629 |
|
| 2007 |
Vialou V, Balasse L, Dumas S, Giros B, Gautron S. Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience. 144: 616-22. PMID 17110048 DOI: 10.1016/J.Neuroscience.2006.09.058 |
0.721 |
|
| 2007 |
Kashani A, Betancur C, Giros B, Hirsch E, El Mestikawy S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiology of Aging. 28: 568-78. PMID 16563567 DOI: 10.1016/J.Neurobiolaging.2006.02.010 |
0.73 |
|
| 2007 |
Lepicard E, Poirel O, Kashani A, Amilhon B, Hirsch E, Epelbaum J, David JP, Delacourte J, Giros B, Betancur C, Mestikawy SE. P.5.b.005 Vesicular glutamate transporters in pathologies of the central nervous system European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70827-1 |
0.335 |
|
| 2006 |
Vazquez V, Giros B, Daugé V. Maternal deprivation specifically enhances vulnerability to opiate dependence. Behavioural Pharmacology. 17: 715-24. PMID 17110797 DOI: 10.1097/Fbp.0B013E3280116E6F |
0.314 |
|
| 2006 |
Vinatier J, Herzog E, Plamont MA, Wojcik SM, Schmidt A, Brose N, Daviet L, El Mestikawy S, Giros B. Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. Journal of Neurochemistry. 97: 1111-25. PMID 16606361 DOI: 10.1111/J.1471-4159.2006.03821.X |
0.798 |
|
| 2006 |
Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 50: 941-52. PMID 16581093 DOI: 10.1016/J.Neuropharm.2006.01.005 |
0.677 |
|
| 2006 |
Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, Phebus LA, Nomikos GG, Giros B. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biological Psychiatry. 59: 508-15. PMID 16199010 DOI: 10.1016/J.Biopsych.2005.08.019 |
0.823 |
|
| 2005 |
Gras C, Vinatier J, Amilhon B, Guerci A, Christov C, Ravassard P, Giros B, El Mestikawy S. Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology. 49: 901-11. PMID 16182324 DOI: 10.1016/J.Neuropharm.2005.07.023 |
0.796 |
|
| 2005 |
Moutsimilli L, Farley S, Dumas S, El Mestikawy S, Giros B, Tzavara ET. Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology. 49: 890-900. PMID 16111724 DOI: 10.1016/J.Neuropharm.2005.06.017 |
0.798 |
|
| 2005 |
Guerriero RM, Rajadhyaksha A, Crozatier C, Giros B, Nosten-Bertrand M, Kosofsky BE. Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Developmental Neuroscience. 27: 235-48. PMID 16046859 DOI: 10.1159/000085997 |
0.336 |
|
| 2005 |
Vazquez V, Farley S, Giros B, Daugé V. Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology. 181: 706-13. PMID 16032413 DOI: 10.1007/S00213-005-0029-0 |
0.545 |
|
| 2005 |
Biala G, Betancur C, Mansuy IM, Giros B. The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. The European Journal of Neuroscience. 21: 3089-96. PMID 15978018 DOI: 10.1111/J.1460-9568.2005.04132.X |
0.652 |
|
| 2005 |
Morice E, Denis C, Macario A, Giros B, Nosten-Bertrand M. Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 575-81. PMID 15354185 DOI: 10.1038/Sj.Npp.1300570 |
0.786 |
|
| 2004 |
Herzog E, Landry M, Buhler E, Bouali-Benazzouz R, Legay C, Henderson CE, Nagy F, Dreyfus P, Giros B, El Mestikawy S. Expression of vesicular glutamate transporters, VGLUT1 and VGLUT2, in cholinergic spinal motoneurons. The European Journal of Neuroscience. 20: 1752-60. PMID 15379996 DOI: 10.1111/J.1460-9568.2004.03628.X |
0.732 |
|
| 2004 |
Morice E, Denis C, Giros B, Nosten-Bertrand M. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. The European Journal of Neuroscience. 20: 120-6. PMID 15245485 DOI: 10.1111/J.1460-9568.2004.03465.X |
0.788 |
|
| 2004 |
Vialou V, Amphoux A, Zwart R, Giros B, Gautron S. Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 2846-51. PMID 15028779 DOI: 10.1523/Jneurosci.5147-03.2004 |
0.684 |
|
| 2004 |
Herzog E, Gilchrist J, Gras C, Muzerelle A, Ravassard P, Giros B, Gaspar P, El Mestikawy S. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience. 123: 983-1002. PMID 14751290 DOI: 10.1016/J.Neuroscience.2003.10.039 |
0.759 |
|
| 2004 |
Roubert C, Spielewoy C, Soubrié P, Hamon M, Giros B, Betancur C. Altered neurotensin mrna expression in mice lacking the dopamine transporter. Neuroscience. 123: 537-46. PMID 14698760 DOI: 10.1016/J.Neuroscience.2003.08.022 |
0.823 |
|
| 2004 |
El Mestikawy S, Kashani A, Gras C, Gilchrist J, Bournaud M, Giros B. S.08.03 Heterogeneity of glutamatergic neurons inthe central nervous systems revealed by the distribution of vesicular glutamate transporter subtypes European Neuropsychopharmacology. 14: S128-S129. DOI: 10.1016/S0924-977X(04)80030-0 |
0.36 |
|
| 2003 |
Crozatier C, Guerriero RM, Mathieu F, Giros B, Nosten-Bertrand M, Kosofsky BE. Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Research. Developmental Brain Research. 147: 97-105. PMID 14741755 DOI: 10.1016/J.Devbrainres.2003.10.006 |
0.304 |
|
| 2003 |
Agulhon C, Rostaing P, Ravassard P, Sagné C, Triller A, Giros B. Lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study. The Journal of Comparative Neurology. 462: 71-89. PMID 12761825 DOI: 10.1002/Cne.10712 |
0.755 |
|
| 2003 |
Giros B, Morice E, Nosten-Bertrand M. S.20.02 Effects of psychostimulants in the absence of dopamine transporter European Neuropsychopharmacology. 13: S149-S150. DOI: 10.1016/S0924-977X(03)91677-4 |
0.435 |
|
| 2002 |
Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5442-51. PMID 12097496 |
0.755 |
|
| 2002 |
Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T. Linkage and association of the glutamate receptor 6 gene with autism. Molecular Psychiatry. 7: 302-10. PMID 11920157 DOI: 10.1038/Sj.Mp.4000979 |
0.314 |
|
| 2002 |
Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM, Gillberg C, Mouren-Siméoni MC, Hamon M, Giros B, Nosten-Bertrand M, Leboyer M. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry. 7: 67-71. PMID 11803447 DOI: 10.1038/Sj/Mp/4000923 |
0.779 |
|
| 2002 |
Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, Mestikawy SE. A Third Vesicular Glutamate Transporter Expressed by Cholinergic and Serotoninergic Neurons The Journal of Neuroscience. 22: 5442-5451. DOI: 10.1523/Jneurosci.22-13-05442.2002 |
0.443 |
|
| 2001 |
Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology. 159: 2-9. PMID 11797063 DOI: 10.1007/S002130100901 |
0.822 |
|
| 2001 |
Gu HH, Wu X, Giros B, Caron MG, Caplan MJ, Rudnick G. The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells. Molecular Biology of the Cell. 12: 3797-807. PMID 11739781 DOI: 10.1091/Mbc.12.12.3797 |
0.527 |
|
| 2001 |
Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: RC181. PMID 11698619 |
0.75 |
|
| 2001 |
Roubert C, Sagné C, Kapsimali M, Vernier P, Bourrat F, Giros B. A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes). Molecular Pharmacology. 60: 462-73. PMID 11502876 |
0.767 |
|
| 2001 |
Sagné C, Agulhon C, Ravassard P, Darmon M, Hamon M, El Mestikawy S, Gasnier B, Giros B. Identification and characterization of a lysosomal transporter for small neutral amino acids. Proceedings of the National Academy of Sciences of the United States of America. 98: 7206-11. PMID 11390972 DOI: 10.1073/Pnas.121183498 |
0.793 |
|
| 2001 |
Syringas M, Janin F, Giros B, Costentin J, Bonnet JJ. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake. British Journal of Pharmacology. 133: 387-94. PMID 11375255 DOI: 10.1038/Sj.Bjp.0704097 |
0.592 |
|
| 2001 |
Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: RC141: 1-4. PMID 11312315 DOI: 10.1523/Jneurosci.21-09-J0001.2001 |
0.83 |
|
| 2001 |
Roubert C, Cox PJ, Bruss M, Hamon M, Bönisch H, Giros B. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. The Journal of Biological Chemistry. 276: 8254-60. PMID 11092898 DOI: 10.1074/Jbc.M009798200 |
0.752 |
|
| 2001 |
Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, Mestikawy SE. The Existence of a Second Vesicular Glutamate Transporter Specifies Subpopulations of Glutamatergic Neurons The Journal of Neuroscience. 21. DOI: 10.1523/Jneurosci.21-22-J0001.2001 |
0.428 |
|
| 2000 |
Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behavioural Pharmacology. 11: 279-90. PMID 11103882 DOI: 10.1097/00008877-200006000-00011 |
0.816 |
|
| 2000 |
Syringas M, Janin F, Mezghanni S, Giros B, Costentin J, Bonnet JJ. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport. Molecular Pharmacology. 58: 1404-11. PMID 11093780 DOI: 10.1124/Mol.58.6.1404 |
0.603 |
|
| 2000 |
Tseng KY, Roubert C, Do L, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gershanik OS, Murer MG, Giros B, Raisman-Vozari R. Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice. Brain Research. Molecular Brain Research. 80: 1-6. PMID 11039723 DOI: 10.1016/S0169-328X(00)00107-8 |
0.792 |
|
| 2000 |
Spielewoy C, Gonon F, Roubert C, Fauchey V, Jaber M, Caron MG, Roques BP, Hamon M, Betancur C, Maldonado R, Giros B. Increased rewarding properties of morphine in dopamine-transporter knockout mice. The European Journal of Neuroscience. 12: 1827-37. PMID 10792459 DOI: 10.1046/J.1460-9568.2000.00063.X |
0.812 |
|
| 2000 |
Masson J, Gaspar P, Aïdouni Z, Ezan P, Giros B, Hamon M, El Mestikawy S. Ontogeny of Rxt1, a vesicular "orphan" Na(+)/Cl(-)-dependent transporter, in the rat. Neuroscience. 96: 627-37. PMID 10717444 DOI: 10.1016/S0306-4522(99)00570-9 |
0.753 |
|
| 2000 |
Dumartin B, Jaber M, Gonon F, Caron MG, Giros B, Bloch B. Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 1879-84. PMID 10677550 DOI: 10.1073/Pnas.97.4.1879 |
0.613 |
|
| 1999 |
Bönisch H, Runkel F, Roubert C, Giros B, Brüss M. The human desipramine-sensitive noradrenaline transporter and the importance of defined amino acids for its function. Journal of Autonomic Pharmacology. 19: 327-33. PMID 10961738 DOI: 10.1111/J.1365-2680.1999.Tb00005.X |
0.739 |
|
| 1999 |
Jaber M, Dumartin B, Sagné C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. The European Journal of Neuroscience. 11: 3499-511. PMID 10564358 DOI: 10.1046/J.1460-9568.1999.00764.X |
0.807 |
|
| 1999 |
Masson J, Cervera P, Côté S, Morisette J, Aïdouni Z, Giros B, Hamon M, Falardeau P, Mestikawy SE. Characterization and distribution of Hxt1, a Na(+)/Cl(-)-dependent orphan transporter, in the human brain. Journal of Neuroscience Research. 56: 146-59. PMID 10494103 DOI: 10.1002/(Sici)1097-4547(19990415)56:2<146::Aid-Jnr4>3.0.Co;2-# |
0.538 |
|
| 1999 |
Masson J, Riad M, Chaudhry F, Darmon M, Aïdouni Z, Conrath M, Giros B, Hamon M, Storm-Mathisen J, Descarries L, El Mestikawy S. Unexpected localization of the Na+/Cl--dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system. The European Journal of Neuroscience. 11: 1349-61. PMID 10103130 DOI: 10.1046/J.1460-9568.1999.00540.X |
0.801 |
|
| 1998 |
Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381 |
0.718 |
|
| 1998 |
Jaber M, Bloch B, Caron MG, Giros B. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation]. Comptes Rendus Des Sã©Ances De La Sociã©Tã© De Biologie Et De Ses Filiales. 192: 1127-37. PMID 10101608 |
0.387 |
|
| 1998 |
Martres MP, Demeneix B, Hanoun N, Hamon M, Giros B. Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain. The European Journal of Neuroscience. 10: 3607-16. PMID 9875340 DOI: 10.1046/J.1460-9568.1998.00366.X |
0.581 |
|
| 1998 |
Cases O, Lebrand C, Giros B, Vitalis T, De Maeyer E, Caron MG, Price DJ, Gaspar P, Seif I. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 6914-27. PMID 9712661 DOI: 10.1523/Jneurosci.18-17-06914.1998 |
0.526 |
|
| 1998 |
Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, Lefkowitz RJ, Caron MG, Koch WJ. Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice. The Journal of Biological Chemistry. 273: 18180-4. PMID 9660778 DOI: 10.1074/Jbc.273.29.18180 |
0.625 |
|
| 1998 |
Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 95: 4029-34. PMID 9520487 DOI: 10.1073/Pnas.95.7.4029 |
0.688 |
|
| 1998 |
Fumagalli F, Jones S, Bossé R, Jaber M, Giros B, Missale C, Wightman RM, Caron MG. Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response, and pituitary function. Advances in Pharmacology (San Diego, Calif.). 42: 179-82. PMID 9327873 DOI: 10.1016/S1054-3589(08)60722-X |
0.631 |
|
| 1998 |
Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. Erratum: Cocaine self-administration in dopamine-transporter knockout mice Nature Neuroscience. 1: 330-330. DOI: 10.1038/1152 |
0.704 |
|
| 1998 |
Spielewoy C, Roubert C, Hamon M, Giros B. Implication of transgenic models for mental disorders: Study of the dopamine neurotransmission system European Neuropsychopharmacology. 8: S119. DOI: 10.1016/S0924-977X(98)80105-3 |
0.791 |
|
| 1997 |
Zhang J, Ferguson SS, Barak LS, Aber MJ, Giros B, Lefkowitz RJ, Caron MG. Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors & Channels. 5: 193-9. PMID 9606723 |
0.63 |
|
| 1997 |
Sagné C, El Mestikawy S, Isambert MF, Hamon M, Henry JP, Giros B, Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. Febs Letters. 417: 177-83. PMID 9395291 DOI: 10.1016/S0014-5793(97)01279-9 |
0.767 |
|
| 1997 |
Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 629-33. PMID 9380041 DOI: 10.1002/Mds.870120502 |
0.696 |
|
| 1997 |
Bossé R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19: 127-38. PMID 9247269 DOI: 10.1016/S0896-6273(00)80353-0 |
0.577 |
|
| 1997 |
Aubert I, Brana C, Pellevoisin C, Giros B, Caille I, Carles D, Vital C, Bloch B. Molecular anatomy of the development of the human substantia nigra. The Journal of Comparative Neurology. 379: 72-87. PMID 9057113 DOI: 10.1002/(Sici)1096-9861(19970303)379:1<72::Aid-Cne5>3.0.Co;2-F |
0.44 |
|
| 1996 |
Masson J, Pohl M, Aïdouni Z, Giros B, Hamon M, el Mestikawy S. The two orphan Na+/Cl(-)-dependent transporters Rxt1 and V-7-3-2 have an overlapping expression pattern in the rat central nervous system. Receptors & Channels. 4: 227-42. PMID 9065971 |
0.726 |
|
| 1996 |
Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J, Lefkowitz RJ, Caron MG, Giros B. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proceedings of the National Academy of Sciences of the United States of America. 93: 12974-9. PMID 8917529 DOI: 10.1073/Pnas.93.23.12974 |
0.611 |
|
| 1996 |
Pifl C, Hornykiewicz O, Giros B, Caron MG. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 277: 1437-43. PMID 8667208 |
0.684 |
|
| 1996 |
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379: 606-12. PMID 8628395 DOI: 10.1038/379606A0 |
0.698 |
|
| 1996 |
Pifl C, Giros B, Caron MG. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse. Advances in Neurology. 69: 235-8. PMID 8615133 |
0.651 |
|
| 1995 |
Masson J, Langlois X, Lanfumey L, Gérard C, Aïdouni Z, Giros B, Hamon M, el Mestikawy S. Immunolabeling of the Na+/Cl(-)-dependent "orphan" transporter Rxt1 in the rat central nervous system. Journal of Neuroscience Research. 42: 423-32. PMID 8583511 DOI: 10.1002/Jnr.490420317 |
0.765 |
|
| 1994 |
el Mestikawy S, Giros B, Pohl M, Hamon M, Kingsmore SF, Seldin MF, Caron MG. Characterization of an atypical member of the Na+/Cl(-)-dependent transporter family: chromosomal localization and distribution in GABAergic and glutamatergic neurons in the rat brain. Journal of Neurochemistry. 62: 445-55. PMID 8294906 DOI: 10.1046/J.1471-4159.1994.62020445.X |
0.813 |
|
| 1994 |
Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. The Journal of Biological Chemistry. 269: 15985-8. PMID 8206893 |
0.654 |
|
| 1994 |
Li T, Yang L, Wiese C, Xu CT, Zeng Z, Giros B, Caron MG, Moises HW, Liu X. No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Research. 52: 17-23. PMID 8047618 DOI: 10.1016/0165-1781(94)90116-3 |
0.334 |
|
| 1994 |
Kingsmore SF, Giros B, Suh D, Bieniarz M, Caron MG, Seldin MF. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nature Genetics. 7: 136-41. PMID 7920630 DOI: 10.1038/Ng0694-136 |
0.485 |
|
| 1994 |
Sabaté O, Campion D, d'Amato T, Martres MP, Sokoloff P, Giros B, Leboyer M, Jay M, Guedj F, Thibaut F. Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia. The American Journal of Psychiatry. 151: 107-11. PMID 7903510 DOI: 10.1176/Ajp.151.1.107 |
0.31 |
|
| 1993 |
Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends in Pharmacological Sciences. 14: 43-9. PMID 8480373 DOI: 10.1016/0165-6147(93)90029-J |
0.593 |
|
| 1993 |
Pifl C, Giros B, Caron MG. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4246-53. PMID 8410185 DOI: 10.1523/Jneurosci.13-10-04246.1993 |
0.738 |
|
| 1993 |
Byerley W, Coon H, Hoff M, Holik J, Waldo M, Freedman R, Caron MG, Giros B. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees. Human Heredity. 43: 319-22. PMID 8406521 DOI: 10.1159/000154151 |
0.551 |
|
| 1993 |
Giros B, Sokoloff P, Martres MP, Lannfelt L, Andrieux M, Besançon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. The third dopamine receptor (D3): new perspectives in therapeutics. Psychopharmacology Series. 10: 82-93. PMID 8103228 DOI: 10.1007/978-3-642-78010-3_8 |
0.53 |
|
| 1993 |
Byerley W, Hoff M, Holik J, Caron MG, Giros B. VNTR polymorphism for the human dopamine transporter gene (DAT1). Human Molecular Genetics. 2: 335. PMID 8098980 DOI: 10.1093/Hmg/2.3.335 |
0.557 |
|
| 1992 |
Sokoloff P, Giros B, Martres MP, Andrieux M, Besancon R, Pilon C, Bouthenet ML, Souil E, Schwartz JC. Localization and function of the D3 dopamine receptor. Arzneimittel-Forschung. 42: 224-30. PMID 1586393 |
0.44 |
|
| 1992 |
Lévesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proceedings of the National Academy of Sciences of the United States of America. 89: 8155-9. PMID 1518841 DOI: 10.1073/Pnas.89.17.8155 |
0.514 |
|
| 1992 |
Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Molecular Pharmacology. 42: 383-90. PMID 1406597 |
0.763 |
|
| 1992 |
Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology. Neurochemistry International. 20: 27S-32S. PMID 1365440 DOI: 10.1016/0197-0186(92)90207-8 |
0.552 |
|
| 1992 |
Martres MP, Sokoloff P, Giros B, Bouthenet ML, Pilon C, Lannfelt L, Schwartz JC. [Dopaminergic receptors, multiple targets for neuroleptics]. Annales Mã©Dico-Psychologiques. 150: 119-23. PMID 1364189 |
0.396 |
|
| 1992 |
Sokoloff P, Andrieux M, Besançon R, Pilon C, Martres MP, Giros B, Schwartz JC. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. European Journal of Pharmacology. 225: 331-7. PMID 1354163 DOI: 10.1016/0922-4106(92)90107-7 |
0.507 |
|
| 1992 |
Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochemical Pharmacology. 43: 659-66. PMID 1347215 DOI: 10.1016/0006-2952(92)90227-A |
0.534 |
|
| 1992 |
Martres MP, Sokoloff P, Giros B, Schwartz JC. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues. Journal of Neurochemistry. 58: 673-9. PMID 1309568 DOI: 10.1111/J.1471-4159.1992.Tb09770.X |
0.545 |
|
| 1992 |
Schwartz JC, Giros B, Martres MP, Sokoloff P. The dopamine receptor family: molecular biology and pharmacology Seminars in Neuroscience. 4: 99-108. DOI: 10.1016/1044-5765(92)90008-P |
0.522 |
|
| 1992 |
Giros B, El Mestikawy S, Godinot N, Yang-Feng T, Caron MG. Molecular cloning, pharmacological characterization and genetic studies of the human dopamine transporter European Neuropsychopharmacology. 2: 268-269. DOI: 10.1016/0924-977X(92)90103-F |
0.784 |
|
| 1991 |
Giros B, Martres MP, Pilon C, Sokoloff P, Schwartz JC. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochemical and Biophysical Research Communications. 176: 1584-92. PMID 2039532 DOI: 10.1016/0006-291X(91)90469-N |
0.532 |
|
| 1991 |
Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C, Schwartz JC, Berger R. Chromosomal localization of the human D3 dopamine receptor gene. Human Genetics. 87: 618-20. PMID 1916765 DOI: 10.1007/Bf00209024 |
0.491 |
|
| 1991 |
Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature. 353: 164-7. PMID 1909771 DOI: 10.1038/353164a0 |
0.47 |
|
| 1991 |
Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Research. 564: 203-19. PMID 1839781 DOI: 10.1016/0006-8993(91)91456-B |
0.515 |
|
| 1991 |
Giros B, el Mestikawy S, Bertrand L, Caron MG. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. Febs Letters. 295: 149-54. PMID 1765147 DOI: 10.1016/0014-5793(91)81406-X |
0.807 |
|
| 1991 |
Schwartz JC, Sokoloff P, Giros B, Martres MP, Andrieux M, Besançon R, Bouthenet ML. The dopamine D3 receptor as a novel target for antipsychotics European Neuropsychopharmacology. 1: 197-199. DOI: 10.1016/0924-977X(91)90482-A |
0.383 |
|
| 1990 |
Llorens-Cortes C, Giros B, Schwartz JC. A novel potential metallopeptidase derived from the enkephalinase gene by alternative splicing. Journal of Neurochemistry. 55: 2146-8. PMID 2230815 DOI: 10.1111/J.1471-4159.1990.Tb05810.X |
0.456 |
|
| 1990 |
Llorens-Cortes C, Van Amsterdam JG, Giros B, Quach TT, Schwartz JC. Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels. Brain Research. Molecular Brain Research. 8: 227-33. PMID 2170800 DOI: 10.1016/0169-328X(90)90021-5 |
0.507 |
|
| 1990 |
Llorens-Cortes C, Giros B, Quach TT, Schwartz JC. Adaptative changes in two indices of enkephalin neuron activity in mouse striatum following GABAergic stimulation. Progress in Clinical and Biological Research. 328: 203-6. PMID 2154779 |
0.41 |
|
| 1990 |
Giros B, Martres MP, Sokoloff P, Schwartz JC. [Gene cloning of human dopaminergic D3 receptor and identification of its chromosome]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 311: 501-8. PMID 2129115 |
0.393 |
|
| 1990 |
Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347: 146-51. PMID 1975644 DOI: 10.1038/347146A0 |
0.523 |
|
| 1990 |
Sokoloff P, Giros B, Martres M, Schwartz J, Bouthenet M. Le troisième récepteur de la dopamine. Une nouvelle cible d'action des neuroleptiques MéDecine/Sciences. 6: 800. DOI: 10.4267/10608/4238 |
0.315 |
|
| 1990 |
Giros B, Sokoloff P, Martres MP, Schwartz JC. Two D2 dopamine receptor isoforms generated via alternative mRNA splicing: regional distribution and effects of haloperidol treatments European Journal of Pharmacology. 183: 1619. DOI: 10.1016/0014-2999(90)91906-R |
0.379 |
|
| 1989 |
Llorens-Cortes C, Martres MP, Van Amsterdam Y, Giros B, Gros C, Pollard H, Schwartz JC. [Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine]. L'Encã©Phale. 15: 105-9. PMID 2743934 |
0.476 |
|
| 1989 |
Malfroy B, Kado-Fong H, Gros C, Giros B, Schwartz JC, Hellmiss R. Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochemical and Biophysical Research Communications. 161: 236-41. PMID 2567164 DOI: 10.1016/0006-291X(89)91586-6 |
0.426 |
|
| 1989 |
Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342: 923-6. PMID 2531847 DOI: 10.1038/342923A0 |
0.52 |
|
| 1988 |
Gros C, Giros B, Schwartz JC, Vlaiculescu A, Costentin J, Lecomte JM. Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound. Neuropeptides. 12: 111-8. PMID 3241626 DOI: 10.1016/0143-4179(88)90040-6 |
0.44 |
|
| 1987 |
Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. The Journal of Pharmacology and Experimental Therapeutics. 243: 666-73. PMID 3479550 |
0.389 |
|
| 1987 |
Michael-Titus A, Preterre P, Giros B, Costentin J. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 243: 1062-6. PMID 3121843 |
0.314 |
|
| 1987 |
Giros B, Gros C, Llorens-Cortes C, Schwartz JC. [Opioid peptides: metabolism and receptors]. Gastroentã©Rologie Clinique Et Biologique. 11: 7B-13B. PMID 3038654 |
0.317 |
|
| 1987 |
Giros B, Schwartz JC. [Opioid peptides and their receptors]. La Revue Du Praticien. 37: 1695-8, 1701-2. PMID 3035700 |
0.319 |
|
| 1987 |
Schwartz JC, Giros B, Gros C, Llorens-Cortes C, Arrang JM, Garbarg M, Pollard H. Novel agents affecting enkephalinergic and histaminergic transmissions in brain. Cephalalgia : An International Journal of Headache. 7: 32-5. PMID 2894899 DOI: 10.1177/03331024870070S610 |
0.437 |
|
| 1986 |
Schwartz JC, de la Baume S, Bouthenet ML, Giros B, Gros C, Llorens-Cortes C, Pollard H, Sales N, Solhonne B, Costentin J. [Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors]. Journal De Pharmacologie. 17: 104-22. PMID 3546953 |
0.326 |
|
| 1986 |
Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices. Peptides. 7: 669-77. PMID 3532054 DOI: 10.1016/0196-9781(86)90043-4 |
0.481 |
|
| 1986 |
Giros B, Llorens-Cortes C, Gros C, Schwartz JC. The endogenous tripeptide Tyr-Gly-Gly as an extracellular metabolite of enkephalins in rat brain: origin and metabolism. Nida Research Monograph. 75: 271-4. PMID 3123944 |
0.412 |
|
| 1986 |
Gros C, Solhonne B, Giros B, Pollard H, Salès N, Schwartz JC, Ronco P, Verroust P. Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes. Nida Research Monograph. 75: 303-6. PMID 2893270 |
0.379 |
|
| 1986 |
Giros B, Gros C, Solhonne B, Schwartz JC. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Molecular Pharmacology. 29: 281-7. PMID 2869404 |
0.357 |
|
| 1985 |
Gros C, Giros B, Schwartz JC. Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M. Neuropeptides. 5: 485-8. PMID 2860607 DOI: 10.1016/0143-4179(85)90060-5 |
0.434 |
|
| 1985 |
Gros C, Giros B, Llorens C, Malfroy B, Pollard H, Pachot I, Schwartz JC, Mazie JC. Enkephalin metabolism and its inhibition. Biochemical Society Transactions. 13: 47-50. PMID 2860040 DOI: 10.1042/Bst0130047 |
0.394 |
|
| 1985 |
Gros C, Giros B, Schwartz JC. Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry. 24: 2179-85. PMID 2859885 DOI: 10.1021/Bi00330A011 |
0.453 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1992 |
Lannfelt L, Sokoloff P, Martres M, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz J. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256. DOI: 10.1097/00041444-199210000-00003 |
0.299 |
|
| 2008 |
Nosten-Bertrand M, Kappeler C, Dinocourt C, Denis C, Germain J, Phan Dinh Tuy F, Verstraeten S, Alvarez C, Métin C, Chelly J, Giros B, Miles R, Depaulis A, Francis F. Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus. Plos One. 3: e2473. PMID 18575605 DOI: 10.1371/Journal.Pone.0002473 |
0.295 |
|
| 2013 |
Naudon L, Piscitelli F, Giros B, Di Marzo V, Daugé V. Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat. Neuropharmacology. 65: 193-9. PMID 23089638 DOI: 10.1016/J.Neuropharm.2012.10.008 |
0.295 |
|
| 2009 |
Morel LJ, Giros B, Daugé V. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2469-76. PMID 19553915 DOI: 10.1038/Npp.2009.70 |
0.294 |
|
| 2020 |
Belzeaux R, Gorgievski V, Fiori LM, Lopez JP, Grenier J, Lin R, Nagy C, Ibrahim EC, Gascon E, Courtet P, Richard-Devantoy S, Berlim M, Chachamovich E, Théroux JF, Dumas S, ... Giros B, et al. GPR56/ADGRG1 is associated with response to antidepressant treatment. Nature Communications. 11: 1635. PMID 32242018 DOI: 10.1038/S41467-020-15423-5 |
0.292 |
|
| 2014 |
Torres-Platas SG, Comeau S, Rachalski A, Bo GD, Cruceanu C, Turecki G, Giros B, Mechawar N. Morphometric characterization of microglial phenotypes in human cerebral cortex. Journal of Neuroinflammation. 11: 12. PMID 24447857 DOI: 10.1186/1742-2094-11-12 |
0.292 |
|
| 2015 |
Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J. Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections. Journal of Inorganic Biochemistry. PMID 26384437 DOI: 10.1016/J.Jinorgbio.2015.07.004 |
0.283 |
|
| 1994 |
Nash SR, Giros B, Kingsmore SF, Rochelle JM, Suter ST, Gregor P, Seldin MF, Caron MG. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Receptors & Channels. 2: 165-74. PMID 7953292 |
0.283 |
|
| 2005 |
Vazquez V, Penit-Soria J, Durand C, Besson MJ, Giros B, Daugé V. Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 4453-62. PMID 15872092 DOI: 10.1523/Jneurosci.4807-04.2005 |
0.277 |
|
| 2020 |
Cutando L, Puighermanal E, Castell L, Tarot P, Bertaso F, Bonnavion P, de Kerchove d'Exaerde A, Isingrini E, Galante M, Dallerac G, Pascoli V, Lüscher C, Giros B, Valjent E. Regulation of GluA1 phosphorylation by d-amphetamine and methylphenidate in the cerebellum. Addiction Biology. e12995. PMID 33368923 DOI: 10.1111/adb.12995 |
0.275 |
|
| 2016 |
De Magalhaes Filho CD, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C, Nosten-Bertrand M, Billard JM, Blaise A, Tronche F, Giros B, Charriaut-Marlangue C, Aïd S, Le Bouc Y, Holzenberger M. Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26762506 DOI: 10.1177/0271678X15626718 |
0.273 |
|
| 2007 |
Schürhoff F, Szöke A, Chevalier F, Roy I, Méary A, Bellivier F, Giros B, Leboyer M. Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 64-8. PMID 17034018 DOI: 10.1002/Ajmg.B.30395 |
0.272 |
|
| 2016 |
Crépeaux G, Eidi H, David MO, Baba-Amer Y, Tzavara E, Giros B, Authier FJ, Exley C, Shaw CA, Cadusseau J, Gherardi RK. Non-linear dose-response of aluminium hydroxide adjuvant particles: selective low dose neurotoxicity. Toxicology. PMID 27908630 DOI: 10.1016/J.Tox.2016.11.018 |
0.266 |
|
| 2010 |
Bai J, Gorgievski V, Tzavara E, Nosten-Bertrand M, Giros B, Otani S. Dopamine Transporter (Dat) Activity Regulates The Induction Of Synaptic Plasticity In Rodent Prefrontal Cortex Schizophrenia Research. 117: 507-507. DOI: 10.1016/J.Schres.2010.02.968 |
0.265 |
|
| 2015 |
Tesone-Coelho C, Morel LJ, Bhatt J, Estevez L, Naudon L, Giros B, Zwiller J, Daugé V. Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation. Addiction Biology. 20: 120-31. PMID 23980619 DOI: 10.1111/Adb.12084 |
0.265 |
|
| 2016 |
Crépeaux G, Eidi H, David M, Giros B, Authier F, Exley C, Shaw C, Cadusseau J, Gherardi RK. Low concentrations of aluminum hydroxide adjuvant, forming limited size aggregates, selectively induce cerebral aluminum increase and long-term neurotoxicity in mouse Morphologie. 100: 160-161. DOI: 10.1016/J.Morpho.2016.07.003 |
0.264 |
|
| 1995 |
Giros B, Pohl M, Rochelle JM, Seldin MF. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sciences. 56: PL369-75. PMID 7752808 DOI: 10.1016/0024-3205(95)00119-Q |
0.263 |
|
| 2006 |
Vazquez V, Penit-Soria J, Durand C, Besson MJ, Giros B, Daugé V. Brief early handling increases morphine dependence in adult rats. Behavioural Brain Research. 170: 211-8. PMID 16567006 DOI: 10.1016/J.Bbr.2006.02.022 |
0.262 |
|
| 2010 |
Fassier C, Hutt JA, Scholpp S, Lumsden A, Giros B, Nothias F, Schneider-Maunoury S, Houart C, Hazan J. Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nature Neuroscience. 13: 1380-7. PMID 20935645 DOI: 10.1038/Nn.2662 |
0.259 |
|
| 1990 |
Sokoloff P, Giros B, Martres MP, Schwartz JC, Bouthenet ML. The third dopamine receptor: a new target for neuroleptics | LE TROISIEME RECEPTEUR DE LA DOPAMINE. UNE NOUVELLE CIBLE D'ACTION DES NEUROLEPTIQUES Medecine/Sciences. 6: 800-802. |
0.254 |
|
| 2014 |
Blum ID, Zhu L, Moquin L, Kokoeva MV, Gratton A, Giros B, Storch K. Author response: A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal Elife. DOI: 10.7554/Elife.05105.017 |
0.253 |
|
| 2009 |
Giros B. CS10-01 Increased dopamine transmission impairs behavioral flexibility and synaptic plasticity European Psychiatry. 24: S193. DOI: 10.1016/S0924-9338(09)70426-2 |
0.252 |
|
| 2014 |
Crépeaux G, Heidi H, David M, Curmi P, Tzavara E, Giros B, Shaw CA, Gherardi RK, Cadusseau J. Assessment of the neurotoxic effects of aluminum hydroxide vaccine adjuvant injections in mice Toxicology Letters. 229: S189. DOI: 10.1016/J.Toxlet.2014.06.643 |
0.251 |
|
| 1994 |
Kim KM, Kingsmore SF, Han H, Yang-Feng TL, Godinot N, Seldin MF, Caron MG, Giros B. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Molecular Pharmacology. 45: 608-17. PMID 8183239 |
0.25 |
|
| 1991 |
Giros B. [Third dopamine receptor. A new target of action of neuroleptics]. Pathologie-Biologie. 39: 252-4. PMID 1676503 |
0.248 |
|
| 2013 |
Germain J, Bruel-Jungerman E, Grannec G, Denis C, Lepousez G, Giros B, Francis F, Nosten-Bertrand M. Abnormal social interaction and reduced aggressive behavior in the Dcx-KO mice. A/Spontaneous social interaction Plos One. DOI: 10.1371/Journal.Pone.0074992.G005 |
0.247 |
|
| 2003 |
Jamain S, Quach H, Betancur C, RÃ¥stam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics. 34: 27-9. PMID 12669065 DOI: 10.1038/Ng1136 |
0.245 |
|
| 2023 |
Markam PS, Bourguignon C, Zhu L, Darvas M, Sabatini PV, Kokoeva MV, Giros B, Storch KF. The neurons that drive infradian sleep-wake and mania-like behavioral rhythms. Biorxiv : the Preprint Server For Biology. PMID 38014299 DOI: 10.1101/2023.11.14.566955 |
0.245 |
|
| 2003 |
Jamain S, Betancur C, Giros B, Leboyer M, Bourgeron T. [Genetics of autism: from genome scans to candidate genes]. Mã©Decine Sciences : M/S. 19: 1081-90. PMID 14648479 DOI: 10.1051/Medsci/200319111081 |
0.242 |
|
| 1991 |
Giros B. The D3 dopamine receptor as a new target for neuroleptics | LE TROISIEME RECEPTEUR DE LA DOPAMINE. UNE NOUVELLE CIBLE D'ACTION DES NEUROLEPTIQUES Semaine Des Hopitaux. 67: 1452-1454. |
0.242 |
|
| 2010 |
Mourlon V, Baudin A, Blanc O, Lauber A, Giros B, Naudon L, Daugé V. Maternal deprivation induces depressive-like behaviours only in female rats. Behavioural Brain Research. 213: 278-87. PMID 20488211 DOI: 10.1016/J.Bbr.2010.05.017 |
0.241 |
|
| 1991 |
Giros B. Dopamine receptors are going to five. Where will be the next step? | CINQ RECEPTEURS POUR LA DOPAMINE: MAIS OU S'ARRETERONT-ILS? Medecine/Sciences. 7: 609-611. |
0.241 |
|
| 2006 |
Etain B, Mathieu F, Rietschel M, Maier W, Albus M, McKeon P, Roche S, Kealey C, Blackwood D, Muir W, Bellivier F, Henry C, Dina C, Gallina S, Gurling H, ... ... Giros B, et al. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Molecular Psychiatry. 11: 685-94. PMID 16534504 DOI: 10.1038/Sj.Mp.4001815 |
0.234 |
|
| 2011 |
Mourlon V, Naudon L, Giros B, Crumeyrolle-Arias M, Daugé V. Early stress leads to effects on estrous cycle and differential responses to stress. Physiology & Behavior. 102: 304-10. PMID 21059366 DOI: 10.1016/J.Physbeh.2010.11.003 |
0.234 |
|
| 1992 |
Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz JC. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256. |
0.227 |
|
| 2004 |
Tzavara E, Li D, Phebus L, Crozatier C, Nomikos G, Giros B. P.2.155Tissue specific endocannabinoid dysregulation in a mouse model of hyperdopaminergia European Neuropsychopharmacology. 14: S300-S301. DOI: 10.1016/S0924-977X(04)80375-4 |
0.225 |
|
| 2003 |
Giros B. Rôle des systèmes de recapture dopaminergiques dans la physiopathologie de l’addiction Psn. 1: 13-18. DOI: 10.1007/Bf03005904 |
0.224 |
|
| 2017 |
Mahar I, Labonte B, Yogendran S, Isingrini E, Perret L, Davoli MA, Rachalski A, Giros B, Turecki G, Mechawar N. Disrupted hippocampal neuregulin-1/ErbB3 signaling and dentate gyrus granule cell alterations in suicide. Translational Psychiatry. 7: e1243. PMID 28949336 DOI: 10.1038/Tp.2017.214 |
0.223 |
|
| 2003 |
Bourgeron T, Giros B. Genetic markers in psychiatric genetics. Methods in Molecular Medicine. 77: 63-98. PMID 12298376 DOI: 10.1385/1-59259-348-8:63 |
0.208 |
|
| 2012 |
Weber T, Bilbao A, Berger S, Giros B, Spanagel R, Bartsch D. P.6.b.002 Compulsive-impulsive alcohol consumption in serotonin deficient vesicular monoamine transporter 2 (Vmat2) knockout mice European Neuropsychopharmacology. 22: S395. DOI: 10.1016/S0924-977X(12)70615-6 |
0.207 |
|
| 2007 |
Mourlon V, Crumeyrolles-Arias M, Giros B, Daugé V. P.1.g.008 Maternal deprivation and reactivity to different stress in male and female adult rats according to their estrous cycle European Neuropsychopharmacology. 17: S307. DOI: 10.1016/S0924-977X(07)70434-0 |
0.195 |
|
| 2020 |
Isingrini E, Guinaudie C, Giros B. Noradrenergic System Variability in Resilience Against Stress Biological Psychiatry. 87: S131. DOI: 10.1016/J.Biopsych.2020.02.352 |
0.195 |
|
| 1998 |
Nash SR, Giros B, Kingsmore SF, Kim KM, el-Mestikawy S, Dong Q, Fumagalli F, Seldin MF, Caron MG. Cloning, gene structure and genomic localization of an orphan transporter from mouse kidney with six alternatively-spliced isoforms. Receptors & Channels. 6: 113-28. PMID 9932288 |
0.181 |
|
| 1996 |
Giros B. As | Le transporteur neuronal de la dopamine : De la protéine à la fonction Medecine/Sciences. 12: 1125-1130. |
0.18 |
|
| 2018 |
Giros B. [Biological psychiatry v3.0]. Medecine Sciences : M/S. 34: 899-900. PMID 30526841 DOI: 10.1051/Medsci/2018242 |
0.177 |
|
| 2017 |
Mahar I, Labonte B, Yogendran S, Isingrini E, Perret L, Davoli MA, Rachalski A, Giros B, Turecki G, Mechawar N. Disrupted hippocampal neuregulin-1/ErbB3 signaling and dentate gyrus granule cell alterations in suicide. Translational Psychiatry. 7: e1161. PMID 28675388 DOI: 10.1038/tp.2017.132 |
0.167 |
|
| 1991 |
Giros B. Cinq récepteurs pour la dopamine : mais où s'arrêteront-ils ? MéDecine/Sciences. 7: 609. DOI: 10.4267/10608/4414 |
0.158 |
|
| 1983 |
Giros B, de la Baume S, Gros C, Schwartz JC. [Inhibition of the evoked liberation of (Met5)enkephalin from slices of globus pallidus in the presence of thiorphan and bestatin]. Comptes Rendus Des Sã©Ances De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 297: 609-12. PMID 6424884 |
0.12 |
|
| 1994 |
Zhang FL, Diehl RE, Kohl NE, Gibbs JB, Giros B, Casey PJ, Omer CA. cDNA cloning and expression of rat and human protein geranylgeranyltransferase type-I. The Journal of Biological Chemistry. 269: 3175-80. PMID 8106351 |
0.096 |
|
| 1998 |
Jaber M, Giros B. Les kinases couplées aux protéines G : désensibilisation des récepteurs β-adrénergiques et régulation de l'activité cardiaque. MéDecine/Sciences. 14: 210. DOI: 10.4267/10608/1012 |
0.01 |
|
| Hide low-probability matches. |